NeoImmuneTech, Inc.

KOSDAQ:A950220 Stock Report

Market Cap: ₩22.3b

NeoImmuneTech Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Luke Yun Oh

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure3.8yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

Companies Like NeoImmuneTech (KOSDAQ:950220) Could Be Quite Risky

Aug 13
Companies Like NeoImmuneTech (KOSDAQ:950220) Could Be Quite Risky

Will NeoImmuneTech (KOSDAQ:950220) Spend Its Cash Wisely?

Mar 22
Will NeoImmuneTech (KOSDAQ:950220) Spend Its Cash Wisely?

CEO

Luke Yun Oh

less than a year

Tenure

Dr. Luke Yun Suk Oh Ph. D. is President of NeoImmuneTech, Inc. from January 15, 2024 and serves as its Chief Executive Officer since March 29, 2024 and serves as its Chairman since 2024. Dr. Oh is an exper...

Leadership Team

NamePositionTenureCompensationOwnership
Luke Yun Oh
President less than a yearno datano data
Tae Woo Kim
Chief Financial Officerno datano datano data
Goongjin Namgoong
Chief Operating Officer4.9yrsno datano data
Byung Lee
Chief Scientific Officer3.8yrsno datano data

3.8yrs

Average Tenure

Experienced Management: A950220's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Luke Yun Oh
President less than a yearno datano data
Rafi Ahmed
Member of Scientific Advisory Board5.1yrsno datano data
Soo-Hyoung Kang
Directorno datano datano data
Jin-Hyoung Kang
Director3.6yrsno datano data
Sung-June Hong
Directorless than a yearno datano data
Richard Kim
Member of Scientific Advisory Board2.3yrsno datano data
Keith Watson
Member of Scientific Advisory Board2.3yrsno datano data
Hyunseok Kang
Member of Scientific Advisory Board2.3yrsno datano data
Young Chae
Member of Scientific Advisory Board2.3yrsno datano data
Benny Chen
Member of Scientific Advisory Board1.4yrsno datano data
Su-Hyung Park
Member of Scientific Advisory Board1.4yrsno datano data
Choonggoo Kang
Directorless than a yearno datano data

2.3yrs

Average Tenure

Experienced Board: A950220's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 16:20
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NeoImmuneTech, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution